Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 4/20 | 0.71 |
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | LMNA | P02545 | 4/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.71 |
| ▸ | GMNN | O75496 | 3/20 | 0.71 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 3/20 | 0.71 |
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.71 |
| ▸ | BLM | P54132 | 2/20 | 0.71 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.71 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.71 |
| ▸ | GLA | P06280 | 1/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.58 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28400574 | 1.00 | MAPK1 (0.71) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL28715063 | 1.00 | MAPK1 (0.71) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL22612677 | 1.00 | MAPK1 (0.71) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL27768116 | 1.00 | MAPK1 (0.71) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL28466494 | 1.00 | MAPK1 (0.71) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL25194019 | 1.00 | MAPK1 (0.71) | MAPK1MAPTLMNACYP1A2GMNN | |
| Hydrochloric Acid SCHEMBL28715044 | 0.99 | MAPK1 (0.69) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL25186738 | 0.99 | CYP1A2 (0.70) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL22392373 | 0.89 | CYP1A2 (0.62) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL17891419 | 0.88 | MEN1 (0.71) | MAPK1MAPTLMNACYP1A2GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250121098-A1 | BRAIN TARGETED NANOPARTICLES OR CONJUGATES AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2025-04-17 | — | — | US | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | UNIV CALIFORNIA (US) | 2025-12-11 | — | — | US | disclosed |
| US-12491217-B2 | Compositions and methods for promoting healthy neural development in an unborn baby | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-09 | — | — | US | disclosed |
| US-12424305-B2 | Closed-loop AI-optimized EMF treatment and digital delivery of data | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250121098-A1 | BRAIN TARGETED NANOPARTICLES OR CONJUGATES AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2025-04-17 | — | — | US | disclosed |
| US-11906510-B2 | Metabolic profiling by reverse-phase/ion-exchange mass spectrometry | STANFORD JUNIOR UNIVERSITY (US) | 2024-02-20 | — | — | US | disclosed |
| US-11850440-B2 | Therapeutic systems using magnetic fields | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2023-12-26 | — | — | US | disclosed |
| CN-115295145-B | Prediction device for hereditary metabolic disease | 国家卫生健康委科学技术研究所 | 2023-07-11 | — | — | CN | disclosed |
| WO-2023129848-A1 | BRAIN TARGETED NANOPARTICLES OR CONJUGATES AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-07-06 | — | — | WO | disclosed |
| US-20220233611-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-28 | — | — | US | disclosed |
| EP-3965820-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | The Regents of the University of California (US) | 2022-03-16 | — | — | EP | disclosed |
| US-20210364498-A1 | METABOLIC PROFILING BY REVERSE-PHASE/ION-EXCHANGE MASS SPECTROMETRY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2021-11-25 | — | — | US | disclosed |
| US-20210052910-A1 | THERAPEUTIC SYSTEMS USING MAGNETIC FIELDS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2021-02-25 | — | — | US | disclosed |
| WO-2020226683-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-11-12 | — | — | WO | disclosed |
| CN-111650314-A | Kit and method for detecting genetic metabolic disease related substances by non-derivation method tandem mass spectrometry | 深圳华大临床检验中心 | 2020-09-11 | — | — | CN | disclosed |
| CN-111100024-A | Method for preparing stable isotope labeled acyl carnitine | 南京谱利健生物技术有限公司 | 2020-05-05 | — | — | CN | disclosed |
| CN-101484808-A | Quantitative analysis of surface-derived samples using mass spectrometry | PERKINELMER LAS INC (US) | 2009-07-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | CYP27A1, LIPC, CYP46A1 | MAPK1 3368/4885MAPT 1772/4885LMNA 2028/4885 |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | IDO1, INMT, IDO2 | MAPK1 3444/4885MAPT 1253/4885LMNA 4468/4885 |
| US-20250121098-A1 | BRAIN TARGETED NANOPARTICLES OR CONJUGATES AND METHODS OF USE THEREOF | SLC2A2, SLC2A3, SLC47A2 | MAPK1 2893/4885MAPT 219/4885LMNA 2508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.